Countdown to Interim Analysis

Thanks to the post by @col69 this morning ( Post #:44910184 ), we've go enough information to speculate on the time point for Interim Analysis.

By my calculations around 5 days to recruitment of first 90 patients



and 4 weeks and 2 days (or around Friday 3 July) to interim analysis:




I explained my reasoning in Post #:44912164 (extract below), but first this brilliant chart posted by @jbs1982 inPost #:44913067:

it's funny you should mention that date wombat according to the chart that I've been playing around with that would put your date in line with the pointy end of the pennant flag ​

​

​

Here's my Post #:44912164 repeated:
It seems to me they are working on a 4 week window (1 month) for recruiting the first 90 patients. This would align with around 2 months to the interim analysis from first dosing (6 May).

So if I update my timeline from date first patient is dosed, this is where I think we are in terms of progress.

I think we are about 1 week from them completing recruitment of the first 90 patients ...

On this timeline we might get an update around Wednesday next wee, i,e, 3 June ...

The 30 day interim analysis will by my calculations be around 3 July.



First patients were dosed 6 May ...

https://www.asx.com.au/asxpdf/20200506/pdf/44hlsx4wdppmkd.pdf



We have various primary and secondary outcomes at 7, 14, 21 and 30 days ...

https://clinicaltrials.gov/ct2/show/NCT04371393?term=mesoblast&recrs=a&draw=2&rank=2